Editas Medicine (EDIT) EPS (Basic) Growth (1y) (2016 - 2025)
Editas Medicine (EDIT) EPS (Basic) Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,151.81% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.81% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 55.40% |
| Jun 30, 2025 | 25.05% |
| Mar 31, 2025 | -18.22% |
| Dec 31, 2024 | -162.72% |
| Sep 30, 2024 | 53.69% |
| Jun 30, 2024 | 88.43% |
| Mar 31, 2024 | 80.51% |
| Dec 31, 2023 | 68.10% |
| Sep 30, 2023 | 92.97% |
| Jun 30, 2023 | 56.11% |
| Mar 31, 2023 | 92.96% |
| Dec 31, 2022 | -69.01% |
| Sep 30, 2022 | -2,238.01% |
| Jun 30, 2022 | -739.83% |
| Mar 31, 2022 | -3,755.50% |
| Dec 31, 2021 | 53.24% |
| Sep 30, 2021 | -886.40% |
| Jun 30, 2021 | -352.00% |
| Mar 31, 2021 | -119.50% |
| Dec 31, 2020 | -41.12% |